Cytochrome P450 Reductase Activity Assay Kit (Colorimetric)
5
(1 Review)
|
(2 Publications)
Cytochrome P450 Reductase Activity Assay Kit (Colorimetric) (ab204704) couples the oxidation of NADPH by cytochrome P450 reductase (CPR) to the reduction of a nearly colorless probe into a brightly colored product with an absorbance peak at OD=460 nm, with the rate of color generation being directly proportional to CPR activity.
View Alternative Names
CYPOR, POR, NADPH--cytochrome P450 reductase, CPR, P450R
- FuncS
Supplier Data
Functional Studies - Cytochrome P450 Reductase Activity Assay Kit (Colorimetric) (AB204704)
Reaction kinetics of recombinant human CPR (positive control) and rat microsomal CPR (with and without inhibitor).
- FuncS
Supplier Data
Functional Studies - Cytochrome P450 Reductase Activity Assay Kit (Colorimetric) (AB204704)
Relative CPR activity detected in rat liver microsomes (RLM, 25 μg total protein) and HepG2 cell lysate (40 μg total protein).
- FuncS
Supplier Data
Functional Studies - Cytochrome P450 Reductase Activity Assay Kit (Colorimetric) (AB204704)
Typical G6P Standard curve using Cytochrome P450 Reductase Activity Assay Kit (Colorimetric) (ab204704). One mole G6P corresponds to one mole of β-NADP+ reduced to NADPH, which subsequently generates one mole of reduced substrate.
Reactivity data
Product details
Cytochrome P450 Reductase Activity Assay Kit (Colorimetric) (ab204704) couples the oxidation of NADPH by cytochrome P450 reductase (CPR) to the reduction of a nearly colorless probe into a brightly colored product with an absorbance peak at OD=460 nm, with the rate of color generation being directly proportional to CPR activity. The NADPH utilized by CPR is generated in situ from β-NADP+ via oxidation of glucose-6-phosphate (G6P) to 6-phospho-D-glucono-1,5-lactone by glucose-6-phosphatase dehydrogenase (G6PDH). The kit can be used to determine CPR activity in a variety of samples, with a detection limit of ~0.2 mU of CPR activity per reaction.
For assessment of CPR activity in crude biological samples that may have extraneous reductases capable of reducing the substrate, an inhibitor of NADPH-dependent flavoproteins is included. In this case, the specific CPR activity may be calculated by running parallel reactions in the presence and absence of inhibitor and subtracting any residual activity detected with the inhibitor present. The kit contains sufficient reagents for performing 100 reactions in a 96-well plate format.
This product is manufactured by BioVision, an Abcam company and was previously called K700 Cytochrome P450 Reductase (CPR) Activity Kit (Colorimetric). K700-100 is the same size as the 100 test size of ab204704.
NADPH-cytochrome P450 reductase (CPR, EC 1.6.2.4) is a ~78 kDa membrane-bound flavoenzyme that catalyzes the transfer of electrons from NADPH to members of the cytochrome P450 monooxidase (CYP) enzyme family in the endoplasmic reticulum. CPR contains two tightly bound flavin cofactors, FAD and FMN, which participate in the sequential transfer of electrons from NADPH→FAD→FMN→CYP, oxidizing NADPH to NADP+ and reducing the CYP heme moiety to the substrate- and oxygen-binding ferrous state. As CPR is required for the function of all CYP isozymes, it plays a critical role in the metabolism of drugs, organic pollutants and other xenobiotic compounds, in addition to its role in biosynthesis of certain vitamins and steroid hormones.
The Safety Datasheet for this product has been updated for certain countries. Please check the current version in the Support and downloads section.
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CPR facilitates electron donation to all microsomal cytochrome P450 enzymes which are involved in a variety of oxidative reactions. This protein is essential for P450 activity assay as it is part of a multienzyme complex that metabolizes exogenous and endogenous compounds efficiently. Without cytochrome P450 reductase the catalytic activity of cytochrome P450 enzymes becomes impaired affecting metabolizing mechanisms for various substances and having systemic biological impacts.
Pathways
Cytochrome P450 reductase directly participates in drug metabolism and steroid biosynthesis pathways. It together with the cytochrome P450 enzymes metabolizes drugs to make them more water-soluble for excretion. The proteins 3 beta-hydroxysteroid dehydrogenase and CYP3A4 are some of the related components within these pathways working in conjunction to achieve metabolic homeostasis. P450 reductase assays are often utilized to study these pathways further understanding the biological roles and interactions of these proteins.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 15:2869 PubMed38693144
2024
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell reports 17:2050-2063 PubMed35961311
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com